Tag: MRSA / Staph Infection
Preop Intranasal Povidone-Iodine Reduces Rate of Surgical Site Infection
Deep surgical site infection rate decreased postintervention in patients undergoing arthroplasty and spine surgery
Oral Switch Noninferior for Low-Risk S. Aureus Bloodstream Infection
Early oral antimicrobial therapy noninferior to intravenous standard therapy for low-risk bloodstream infection
Ceftobiprole Noninferior to Daptomycin for Complicated Staph Infection
Ceftobiprole noninferior for overall treatment success; findings consistent in key subgroups and for secondary outcomes
Nasal Colonization With Staph Bacteria Linked to Acute Radiation Dermatitis
Bacterial decolonization effective for acute radiation dermatitis prophylaxis in patients with breast, head and neck cancer
Disparities Seen in Staph Bloodstream Infections in Hemodialysis
S. aureus bloodstream infection risk highest in Hispanic patients and in those aged 18 to 49 years
Some Multidrug-Resistant Bacterial Infections Down in U.S.
MRSA, vancomycin-resistant enterococcal, MDR P. aeruginosa infection rates fell from 2012 to 2017
Household Environment Plays Role in MRSA Acquisition
Frequent handwashing may reduce likelihood of novel strain introduction into the household
Private Rooms Help Sustain Lower Rates of Some Nosocomial Colonization
Reduction seen in VRE infections, colonization; MRSA colonization but not infection reduced
Active Bathing in Non-ICU Setting Does Not Cut Infections
No change seen in risk for hospital-acquired infections overall; benefit seen for those with medical devices
Hospital-Onset MRSA Decreased From 2002 to 2015
S. aureus infections also dropped overall at VA medical centers after MRSA prevention program initiation
